Biomagnetics Diagnostics Corp. Stock

Stocks

BMGP

US09062Q1085

Advanced Medical Equipment & Technology

OTC Markets Traded
Market Closed - 20:43:25 20/08/2026 +03 5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Biomagnetics Diagnostics Corp. -.--% -

Valuation: Biomagnetics Diagnostics Corp.

Market Cap 3.23M 2.84M 2.67M 2.44M 4.56M 310M 4.6M 31.99M 12.41M 158M 12.12M 11.85M 512M P/E 2009
-6.29x
P/E 2010 -22.9x
Enterprise Value 3.36M 2.96M 2.79M 2.55M 4.76M 323M 4.8M 33.35M 12.94M 164M 12.63M 12.36M 534M EV / Sales 2009
-
EV / Sales 2010 -
Free-Float
100%
Yield 2009 *
-
Yield 2010 -
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
0.01
Manager TitleAgeSince
Chief Executive Officer - 26/02/1997
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 277
+1.97%+4.62%+44.42%+34.93% 246B
+1.00%+7.40%+17.95%-9.90% 156B
+0.31%+4.51%-10.77%+38.63% 141B
+0.13%+1.75%-54.26%-16.64% 64.66B
-1.26%-3.98%+14.97%+23.07% 50.04B
+0.03%-3.00%-20.96%-21.61% 47.18B
+4.55%+12.46%+37.24%+55.14% 46.61B
+2.31%+2.79%+43.81%+59.96% 41.32B
+7.25%+19.64%+175.64%+106.81% 38.56B
Average +1.37%+3.21%+27.56%+30.04% 83.08B
Weighted average by Cap. +0.98%+3.64%+22.60%+24.93%

Financials

2009 2010
Net sales - -
Net income -1.17M -1.03M -970K -887K -1.66M -112M -1.67M -11.62M -4.51M -57.27M -4.4M -4.3M -186M -238K -209K -197K -180K -337K -22.86M -340K -2.36M -916K -11.65M -895K -875K -37.84M
Net Debt 126K 111K 104K 95.42K 178K 12.1M 180K 1.25M 485K 6.16M 473K 463K 20.03M 137K 121K 114K 104K 194K 13.19M 196K 1.36M 529K 6.72M 516K 505K 21.83M
Logo Biomagnetics Diagnostics Corp.
Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. The Company’s diagnostics system focuses on real-time testing for the actual presence of the virus or toxin or disease itself and not for antibodies produced by the body's immune system which may take anywhere from weeks to months to appear. The Company’s products include High Throughput Screening - Magnetic Testing Platform (HTS-MTP) and Integrity Optical Biosensor (IOBS). Its HTS-MTP is designed to detect both qualitative chemical identification of the elements present in a substance and quantitative number of specific elements in a substance results from a single test. The Company triggered optical biosensor that is based on protein-receptor binding that brings two or more optically tagged receptors into close proximity using planar optical waveguides, thereby triggering fluorescence changes identified almost instantly by tiny on-board detectors.
Employees
2
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. BMGP Stock